Michael Brian Bell - 01 Jul 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Reporting relationship: Chief Financial Officer
Issuer ticker: GH
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 18:10:17 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John G. Saia, as attorney-in-fact for Michael Brian Bell

Key filing fact

Michael Brian Bell filed Form 4 for Guardant Health, Inc. (GH) on 02 Jul 2026.

Key facts

This page summarizes Michael Brian Bell's Form 4 filing for Guardant Health, Inc. (GH).
7 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 02 Jul 2026, 18:10.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001702824 Primary reporting owner

Bell Michael Brian

Relationship: Chief Financial Officer
Address: 3100 HANOVER STREET, PALO ALTO
Signature: /s/ John G. Saia, as attorney-in-fact for Michael Brian Bell
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,084
Change %: +4.3%
Price: $0.000000^*
Shares after: 50,536
Date: 01 Jul 2026
Ownership: Direct

GH transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,324
Change %: +6.6%
Price: $0.000000^*
Shares after: 53,860
Date: 01 Jul 2026
Ownership: Direct

GH transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,870
Change %: +3.5%
Price: $0.000000^*
Shares after: 55,730
Date: 01 Jul 2026
Ownership: Direct

GH transaction

Common Stock

Tax liability

Transaction value
Shares: -3,914
Change %: -7%
Price: $170.77^*
Shares after: 51,816
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -2,084
Change %: -50%
Price: $0.000000^*
Shares after: 2,085
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,084
Exercise price: $0.000000
Footnotes: F2, F3

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -3,324
Change %: -17%
Price: $0.000000^*
Shares after: 16,620
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,324
Exercise price: $0.000000
Footnotes: F3, F4

GH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -1,870
Change %: -12%
Price: $0.000000^*
Shares after: 13,093
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,870
Exercise price: $0.000000
Footnotes: F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.

Footnote F2

This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Footnote F3

Not applicable for Restricted Stock Units.

Footnote F4

This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Footnote F5

This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.